Afya Ltd current report, Q4 FY2023

Afya Limited Form 6-K Summary

Business context and reporting period

Afya Limited filed this Form 6-K as a foreign private issuer for March 2024. The filing presents, as Exhibit 99.1, consolidated financial statements as of December 31, 2023 and 2022, and for the years ended December 31, 2023, 2022, and 2021.

Financial metrics

The provided filing text contains only the Form 6-K cover page and does not include the underlying consolidated financial statements. Revenue, profit, cash flow, margins, debt, liquidity, and other financial metrics are therefore not available from the supplied text.

Material changes versus prior periods

The filing identifies comparative financial statements for 2023, 2022, and 2021, but the supplied text does not provide the amounts or disclosures necessary to assess changes between periods.

Guidance, outlook, risks, and unusual items

No guidance, outlook, management commentary, risk disclosures, contingencies, or unusual items are included in the supplied filing text. The filing references Exhibit 99.1, which may contain additional information.

Investor verification points

  • Obtain and review Exhibit 99.1, including the consolidated balance sheets, statements of income, cash flows, and equity.
  • Verify 2023 revenue, profitability, operating cash flow, adjusted metrics, debt balances, and liquidity.
  • Review notes to the financial statements for acquisitions, commitments, contingencies, related-party transactions, and subsequent events.
  • Assess the company’s reported 2023 results against 2022 and 2021 comparatives once the complete exhibit is available.